Relative Effectiveness and Safety of the GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists, Semaglutide and Liraglutide in the Treatment of Obese Type 2 Diabetics: A Prospective Observational Cohort Study in Poland
Semaglutide was more effective than liraglutide in reducing HbA1c and BMI. Gastrointestinal symptoms were the most frequent side effects in both groups.
Authors
- Anna Paczkowska (ORCID: https://orcid.org/0000-0002-0058-2632)
- Michał Michalak (ORCID: https://orcid.org/0000-0002-2852-3984)
- Karolina Hoffmann (ORCID: https://orcid.org/0000-0001-6148-4094)
Institutions
- Poznan University of Medical Sciences (PL)
Publication Details
- Journal
- Diabetes Metabolic Syndrome and Obesity
- Published
- 2025-08-01
- DOI
- https://doi.org/10.2147/dmso.s531697
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.88